The LEMM is one of four partners MetaboHUB, a National Infrastructure in Biology and Health coordinates the development of technologies and methodologies in the field of metabolomics and fluxomics to characterize the biochemical level large sets of samples. Researchers LEMM are working to characterize biomarkers in the areas of neurology, oncology, genetic diseases of the red cell and microbiology.